Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2 ...Middle East

Medscape - News
The "twincretin" tirzepatide (Mounjaro) met its primary endpoints compared with placebo in the SURMOUNT-2 trial, designed to test weight loss efficacy, in top-line results reported by Lilly. Medscape Medical News

Hence then, the article about tirzepatide scores win in second obesity trial surmount 2 was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News